Effect of previous interferon treatment on the recurrence of hepatocellular carcinoma in patients with hepatitis C

被引：0
|
作者：
Miyatake, Hirokazu
Kobayashi, Yoshiyuki
Iwasaki, Yoshiaki
Nakamura, Shinichirou
Tanaka, Hironori
Miyake, Yasuhiro
Terada, Ryo
Miyoshi, Kenji
Ohnishi, Hideki
Iwadou, Shouta
Shouji, Bon
Kuwaki, Takeshi
Sakaguchi, Kohsaku
Shiratori, Yasushi
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A497 / A497
页数：1
相关论文
共 50 条
  • [41] Appropriate treatment for recurrence prevention in chronic hepatitis-C and resection of hepatocellular carcinoma
    Malfertheiner, MP
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (48) : 2580 - 2580
  • [42] Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?
    Harper, SE
    Dienstag, JL
    HEPATOLOGY, 1996, 23 (04) : 930 - 933
  • [43] The risk of hepatocellular carcinoma and decompensation following hepatitis C treatment with interferon based therapy
    Jamil, Khaleel
    Cheng, Wendy
    Tarquinio, Lorenzo
    Adams, Leon
    Mollison, Lindsay
    MacQuillan, Gerry
    DeBoer, Bastion
    McInerney, Marion
    Nazareth, Saroj
    Connelly, Crystal
    Flexman, James
    Kontorinis, Nick
    HEPATOLOGY, 2006, 44 (04) : 331A - 332A
  • [44] The risk of hepatocellular carcinoma and decompensation following hepatitis C treatment with interferon based therapy
    Jamil, K. M.
    Cheng, W.
    Tarqunio, L.
    Adams, L.
    Mollison, L.
    Macquillan, G.
    De Boer, B.
    Mcinerney, M.
    Nazareth, S.
    Connelly, C.
    Flexman, J.
    Kontorinis, N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A328 - A328
  • [45] Efficacy of pegylated interferon based treatment in patients with hepatitis C refractory to previous conventional interferon-based treatment
    Shaikh, Samiullah
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 209 - 209
  • [46] INTERFERON AND RISK OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C RELATED CIRRHOSIS
    Kimer, Nina
    Gluud, Lise L.
    Dahl, Emilie K.
    Krag, Aleksander
    HEPATOLOGY, 2011, 54 : 1272A - 1272A
  • [47] INTERFERON THERAPY FOR HEPATITIS C PATIENTS CURATIVELY TREATED FOR HEPATOCELLULAR CARCINOMA WITH PERCUTANEOUS THERAPIES
    Goto, Tadashi
    Yoshida, Haruhiko
    Tateishi, Ryosuke
    Enooku, Kenichiro
    Goto, Eriko
    Yoshida, Hideo
    Sato, Takahisa
    Ohki, Takamasa
    Masuzaki, Ryota
    Imamura, Jun
    Yamashiki, Noriyo
    Kanai, Fumihiko
    Hamamura, Keisuke
    Shiina, Shuichiro
    Kawabe, Takao
    Omata, Masao
    HEPATOLOGY, 2008, 48 (04) : 861A - 861A
  • [48] Risk factors for hepatocellular carcinoma among chronic hepatitis C patients treated with interferon
    Kasahara, A
    Hayashi, N
    Kakumu, S
    Kiyosawa, K
    Okita, K
    HCV AND RELATED LIVER DISEASES, 1999, : 103 - 117
  • [49] Effects of interferon therapy on inhibition of hepatocellular carcinoma development in patients with chronic hepatitis C
    Shiratori, Y
    Yoshida, H
    Omata, I
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (05) : 213 - 214
  • [50] Interferon retreatment reduces or delays the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Hino, K
    Kitase, A
    Satoh, Y
    Fujiwara, D
    Yamaguchi, Y
    Korenaga, M
    Shingai, Y
    Konishi, T
    Yamashita, S
    Uchida, K
    Mori, K
    Hanada, H
    Kodama, T
    Nukui, K
    Okita, K
    JOURNAL OF VIRAL HEPATITIS, 2002, 9 (05) : 370 - 376
12345